World Journal of Gastroenterology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Maslennikov R, Ivashkin V, Efremova I, Poluektova E, Kudryavtseva A, Krasnov G. Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis. World J Gastroenterol 2022; 28(10): 1067-1077 [PMID: 35431497 DOI: 10.3748/wjg.v28.i10.1067]
URL:	https://www.wjgnet.com/1007-9327/full/v28/i10/1067.htm

(278) (292) (0) (0) (0) (5) (7526) (24)

Number	Citing Articles
1	Irina Efremova, Roman Maslennikov, Elena Poluektova, Ekaterina Vasilieva, Yury Zharikov, Andrey Suslov, Yana Letyagina, Evgenii Kozlov, Anna Levshina, Vladimir Ivashkin. Epidemiology of small intestinal bacterial overgrowth. World Journal of Gastroenterology 2023; 29(22): 3400-3421 doi: 10.3748/wjg.v29.i22.3400 Abstract(1595) \| Core Tip(1061) \| Full Article(HTML)(29353) \| Full Article (PDF)-605K(1275) \| Full Article with Cover (PDF)-1256K(401) \| Full Article (Word)-195K(53) \| Full Article (XML)-330K(212) \| Audio-930K(38) \| Peer-Review Report-241K(188) \| Answering Reviewers-118K(189) \| Times Cited (73) \| Total Visits (32957) \| Open
2	Mehran Mahooti, Fatemeh Safaei, Elahe Abdolalipour, Ghazale Ahmadbeigi, Hadiseh Shokouhi, Tina Fallah, Davood Zare. Short-chain fatty acid–producing probiotics: an effective approach for modulating gut dysbiosis and mitigating inflammatory responses. Microbial Pathogenesis 2026; 216 doi: 10.1016/j.micpath.2026.108520
3	Mervin W. Villalobos-Orozco. Alteración de la microbiota intestinal y su relación con enfermedades gastrointestinales y hepatobiliares. Hepatología 2023; 4(1) doi: 10.52784/27112330.168
4	Irina Efremova, Roman Maslennikov, Aliya Alieva, Elena Poluektova, Vladimir Ivashkin. Small Intestinal Bacterial Overgrowth Is Associated with Poor Prognosis in Cirrhosis. Microorganisms 2023; 11(4) doi: 10.3390/microorganisms11041017
5	Paulina Roszkowska, Emilia Klimczak, Ewa Ostrycharz, Aleksandra Rączka, Iwona Wojciechowska-Koszko, Andrzej Dybus, Yeong-Hsiang Cheng, Yu-Hsiang Yu, Szymon Mazgaj, Beata Hukowska-Szematowicz. Small Intestinal Bacterial Overgrowth (SIBO) and Twelve Groups of Related Diseases—Current State of Knowledge. Biomedicines 2024; 12(5) doi: 10.3390/biomedicines12051030
6	Qi-Qi Xie, Jia-Feng Wang, Yang-Fen Zhang, Dong-Hui Xu, Bo Zhou, Ting-Hui Li, Zhi-Peng Li. Glucose substrate in the hydrogen breath test for gut microbiota determination: A recommended noninvasive test. World Journal of Clinical Cases 2022; 10(26): 9536-9538 doi: 10.12998/wjcc.v10.i26.9536 Abstract(1286) \| Core Tip(868) \| Full Article(HTML)(2481) \| Full Article (PDF)-1462K(304) \| Full Article (Word)-104K(55) \| Audio-816K(12) \| Peer-Review Report-187K(164) \| Answering Reviewers-132K(177) \| Times Cited (1) \| Total Visits (2879) \| Open
7	André Pontes-Silva, André Luiz Lopes, Erika da Silva Maciel, Fernando Rodrigues Peixoto Quaresma, Almir Vieira Dibai-Filho. Human metabolism and body composition: prospects for novel studies. Nutrition Reviews 2023; 82(1) doi: 10.1093/nutrit/nuad040
8	Irina Efremova, Roman Maslennikov, Oleg Medvedev, Anna Kudryavtseva, Anastasia Avdeeva, George Krasnov, Filipp Romanikhin, Mikhail Diatroptov, Maria Fedorova, Elena Poluektova, Anna Levshina, Vladimir Ivashkin. Gut Microbiota and Biomarkers of Intestinal Barrier Damage in Cirrhosis. Microorganisms 2024; 12(3) doi: 10.3390/microorganisms12030463
9	Nian-Song Kang, Hai-Jun Fang, Si-Hui Zheng. Gut-liver axis management and its surgical application: A perspective from “liver governing free flow”. World Journal of Gastrointestinal Surgery 2026; 18(5): 117321 doi: 10.4240/wjgs.v18.i5.117321 Abstract(7) \| Core Tip(5) \| Full Article(HTML)(15) \| Full Article (PDF)-952K(5) \| Full Article with Cover (PDF)-1170K(4) \| Full Article (XML)-125K(1) \| Audio-241K(1) \| Peer-Review Report-229K(3) \| Answering Reviewers-50K(3) \| Times Cited (0) \| Total Visits (35) \| Open
10	Siyuan Sun, Guangheng Zhang, Shimeng Lv, Jinhui Sun. Potential mechanisms of traditional Chinese medicine in the treatment of liver cirrhosis: a focus on gut microbiota. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1407991
11	Eden Sharabi, Ali Rezaie. Small Intestinal Bacterial Overgrowth. Current Infectious Disease Reports 2024; 26(11) doi: 10.1007/s11908-024-00847-7
12	Roman Maslennikov, Aliya Alieva, Elena Poluektova, Yury Zharikov, Andrey Suslov, Yana Letyagina, Ekaterina Vasileva, Anna Levshina, Evgenii Kozlov, Vladimir Ivashkin. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota. World Journal of Gastroenterology 2023; 29(27): 4236-4251 doi: 10.3748/wjg.v29.i27.4236 Abstract(1150) \| Core Tip(1068) \| Full Article(HTML)(5650) \| Full Article (PDF)-967K(465) \| Full Article with Cover (PDF)-2077K(300) \| Full Article (Word)-351K(72) \| Full Article (XML)-396K(214) \| Audio-395K(32) \| Peer-Review Report-291K(186) \| Answering Reviewers-97K(194) \| Times Cited (26) \| Total Visits (8382) \| Open
13	Yifan Zhang, Hongkun Li, Fei Yu, Mengmeng Gao, Yang Wang, Siyu Xin, Jiating Yang, Zhiwei Wang, Lujie Xiang, Qingjing Ru, Na Jiang. The role of Traditional Chinese Medicine in the management of liver disease: targeting gut microbiome. Chinese Medicine 2026; 21(1) doi: 10.1186/s13020-026-01395-z
14	Dmitry Victorovich Garbuzenko. Therapeutic possibilities of gut microbiota modulation in acute decompensation of liver cirrhosis. World Journal of Hepatology 2023; 15(4): 525-537 doi: 10.4254/wjh.v15.i4.525 Abstract(948) \| Core Tip(963) \| Full Article(HTML)(3505) \| Full Article (PDF)-590K(220) \| Full Article with Cover (PDF)-1866K(346) \| Full Article (Word)-239K(397) \| Audio-1509K(45) \| Peer-Review Report-221K(173) \| Answering Reviewers-113K(175) \| Times Cited (4) \| Total Visits (5410) \| Open
15	Tary Salman, Gasser El-Azab, Fatma Khalil, Reham Elkazaz, Abdelaleem Helal. Association of small intestinal bacterial overgrowth with portal hypertension in HCV-related cirrhosis: a cross-sectional study. Clinical and Experimental Medicine 2026; 26(1) doi: 10.1007/s10238-025-01871-0
16	Ya-Nan Li, Na-Ling Kang, Jia-Ji Jiang, Yue-Yong Zhu, Yu-Rui Liu, Da-Wu Zeng, Fei Wang. Gut microbiota of hepatitis B virus-infected patients in the immune-tolerant and immune-active phases and their implications in metabolite changes. World Journal of Gastroenterology 2022; 28(35): 5188-5202 doi: 10.3748/wjg.v28.i35.5188 Abstract(1032) \| Core Tip(1330) \| Full Article(HTML)(3389) \| Full Article (PDF)-10021K(398) \| Full Article (Word)-2919K(103) \| Audio-1963K(12) \| Peer-Review Report-658K(179) \| Answering Reviewers-205K(162) \| Supplementary Material-641K(176) \| Times Cited (13) \| Total Visits (5110) \| Open
17	Shiqi Zhang, Pinglan Li, Suwon Lee, Yu Wang, Chunming Tan, Nan Shang. Weizmannia coagulans: an Ideal Probiotic for Gut Health . Food Science and Human Wellness 2023; doi: 10.26599/FSHW.2022.9250002
18	Irina Efremova, Roman Maslennikov, Maria Zharkova, Elena Poluektova, Nona Benuni, Aleksandr Kotusov, Tatyana Demina, Aleksandra Ivleva, Farida Adzhieva, Taisiya Krylova, Vladimir Ivashkin. Efficacy and Safety of a Probiotic Containing Saccharomyces boulardii CNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis: Randomized, Placebo-Controlled Study. Journal of Clinical Medicine 2024; 13(3) doi: 10.3390/jcm13030919
19	D.V. Garbuzenko. Gut microbiota modulation in acute decompensation of liver cirrhosis: theory and therapeutic potential. Dokazatel'naya gastroenterologiya 2022; 11(4) doi: 10.17116/dokgastro20221104165
20	Elias Xirouchakis, Alexandros Pelekanos, Spyridon Xirouchakis, Hariklia Kranidioti, Spilios Manolakopoulos. A Systematic Review of Microbiota in Cirrhosis: A Change Towards a More Pathogenic Predisposition. International Journal of Molecular Sciences 2025; 26(2) doi: 10.3390/ijms26020527
21	Aneta Kiecka, Marian Szczepanik. Proton pump inhibitor-induced gut dysbiosis and immunomodulation: current knowledge and potential restoration by probiotics. Pharmacological Reports 2023; 75(4) doi: 10.1007/s43440-023-00489-x
22	Yu. N. Alekhin, V. S. Ponamarev, O. S. Popova. Pathogenetic bases of the combined use of drugs from the groups of hepatoprotectors and phytosorbents. International Journal of Veterinary Medicine 2022; (2) doi: 10.52419/issn2072-2419.2022.2.47
23	Xue Li, Xinyi Xu, Sian Tao, Yue Su, Li Wen, Dong Wang, Jibin Liu, Quansheng Feng. Gut microbes combined with metabolomics reveal the protective effects of Qijia Rougan decoction against CCl4-induced hepatic fibrosis. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1347120